Showing results (21-30 of 56) with videos related to
Sort By:
Pageof 6
Journal of Medicinal Chemistry|May 6, 2020
Discovery of a First-in-Class Protein Arginine Methyltransferase 6 (PRMT6) Covalent InhibitorYudao Shen, Fengling Li, Magdalena M Szewczyk, et al.Journal of Chemical Information and Modeling|June 23, 2023
Discovery of a Novel DCAF1 Ligand Using a Drug-Target Interaction Prediction Model: Generalizing Machine Learning to New Drug TargetsSerah W Kimani, Julie Owen, Stuart R Green, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentKarina Leal, Elizabeth L Zoeller, Gregory A Cary, et al.The Journal of Biological Chemistry|December 17, 2013
Class I major histocompatibility complex, the trojan horse for secretion of amyloidogenic β2-microglobulinLevon Halabelian, Stefano Ricagno, Sofia Giorgetti, et al.Journal of Chemical Information and Modeling|June 25, 2024
Subpocket Similarity-Based Hit Identification for Challenging Targets: Application to the WDR Domain of LRRK2Merveille Eguida, Guillaume Bret, François Sindt, et al.Journal of Medicinal Chemistry|October 2, 2023
Discovery of a 53BP1 Small Molecule Antagonist Using a Focused DNA-Encoded Library ScreenDevan J Shell, Caroline A Foley, Qinhong Wang, et al.Nature Communications|April 1, 2024
Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicingLei Shen, Xiaokuang Ma, Yuanyuan Wang, et al.PNAS Nexus|April 26, 2024
Probing the CRL4DCAF12 interactions with MAGEA3 and CCT5 di-Glu C-terminal degronsGermanna Lima Righetto, Yanting Yin, David M Duda, et al.Nature Biotechnology|March 2, 2021
Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cellsKenji Sugata, Yukiko Matsunaga, Yuki Yamashita, et al.Chemmedchem|June 24, 2021
Development of LM98, a Small-Molecule TEAD Inhibitor Derived from Flufenamic AcidLéa Mélin, Shuay Abdullayev, Ahmed Fnaiche, et al.Pageof 6